Apple's Next Project: Tackling Heart Disease
Apple Inc. (NASDAQ: AAPL) is launching the Apple Heart Study, a program that will explore if using the Apple Watch to monitor heart rhythm can benefit patients, healthcare providers, and insurers. The study could save lives and drive demand for its products, so let's take a closer look.
Wearables represent a massive opportunity to improve patient health and, as a result, Apple's investing in hardware and software that can provide life-saving insight for people with an undiagnosed or chronic disease.
Image source: Getty Images.
Source: Fool.com
Apple Inc. Stock
€209.55
-2.600%
Our community is currently high on Apple Inc. with 140 Buy predictions and 14 Sell predictions.
As a result the target price of 214 € shows a slightly positive potential of 2.12% compared to the current price of 209.55 € for Apple Inc..
